InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for the month of February 2023. The report was filed on February 1, 2023, under Commission File Number 001-40614. The filing identifies the company’s principal executive office in Herzliya, Israel and indicates that it files annual reports on Form 20-F.
Financial Metrics
The provided filing text does not include financial statements, revenue, profit, cash flow, margins, debt, liquidity, or other quantitative financial metrics.
Material Changes Versus Prior Period
The filing text does not provide a clear description of material changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing lists Exhibit 99.1, a press release dated February 1, 2023, but the press release content is not included in the provided text. Accordingly, guidance, outlook, management commentary, risks, contingencies, and unusual items cannot be assessed from this filing text.
Key Facts to Verify
- Obtain and review Exhibit 99.1, the February 1, 2023 press release.
- Verify whether the missing exhibit contains financial results, operating metrics, guidance, or material developments.
- Confirm any reported figures or disclosures against InterCure’s applicable Form 20-F and other SEC filings.